| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8721216 | Clinical Immunology | 2018 | 34 Pages |
Abstract
In summary, in this study it was shown that patients with active SLE display increased Th17 and functional Th1/17 cells. This impaired T-cell axis might represent a possible future therapeutic target.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Anastasia Tsanaktsi, Elena E. Solomou, Stamatis-Nick C. Liossis,